drugset / Trial / NCT01135368
Safety and Efficacy of Lansoprazole in Patients With Reflux Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to measure the safety, efficacy and quality of life of lansoprazole in patients with reflux disease over a five year period.
Timeline
- Start
- 2002-06
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lansoprazole | Other / unclassified | 15 mg | Oral |
| Subject | Lansoprazole | Other / unclassified | 30 mg | Oral |